Canonical ingredient
BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER)
24 linked products
Official identifiers
Names and synonyms
- Bortézomib (Bortézomib, ester boronique de mannitol) (fr)
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
ACT BORTEZOMIB
3.5 · MG · VIAL
BORTEZOMIB
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
2.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
1 · MG · VIAL
BORTEZOMIB FOR INJECTION
3 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
1 · MG · VIAL
BORTEZOMIB FOR INJECTION
2.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION
3.5 · MG · VIAL
BORTEZOMIB FOR INJECTION SDZ
3.5 · MG · VIAL
BORTEZOMIB INJECTION
2.5 · MG · ML
PMS-BORTEZOMIB
3.5 · MG · VIAL
TARO-BORTEZOMIB
3.5 · MG · VIAL
TARO-BORTEZOMIB
2.5 · MG · VIAL
TARO-BORTEZOMIB
1 · MG · VIAL
VELCADE
3.5 · MG · VIAL